[go: up one dir, main page]

CY1116844T1 - Purine derivatives for use in the treatment of allergic, inflammatory and infectious diseases - Google Patents

Purine derivatives for use in the treatment of allergic, inflammatory and infectious diseases

Info

Publication number
CY1116844T1
CY1116844T1 CY20151100852T CY151100852T CY1116844T1 CY 1116844 T1 CY1116844 T1 CY 1116844T1 CY 20151100852 T CY20151100852 T CY 20151100852T CY 151100852 T CY151100852 T CY 151100852T CY 1116844 T1 CY1116844 T1 CY 1116844T1
Authority
CY
Cyprus
Prior art keywords
treatment
allergic
infectious diseases
inflammatory
purine derivatives
Prior art date
Application number
CY20151100852T
Other languages
Greek (el)
Inventor
Keith Biggadike
Diane Mary Coe
Xiao Qing Lewell
Charlotte Jane Mitchell
Stephen Allan Smith
Naimisha Trivedi
Original Assignee
Glaxosmithkline Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP09781606.0A external-priority patent/EP2324026B1/en
Application filed by Glaxosmithkline Llc filed Critical Glaxosmithkline Llc
Publication of CY1116844T1 publication Critical patent/CY1116844T1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Ενώσεις του τύπου (I) όπου το R1 είναι C1-6αλκυλαμινο, C1-6αλκοξυ, ή C3-7κυκλοαλκυλοξυ· το m είναι ακέραιος με τιμή 3 ως 6· το n είναι ακέραιος με τιμή 0 ως 4· κι άλατα αυτών είναι επαγωγείς ανθρώπινης ιντερφερόνης. Ενώσεις που επάγουν την ανθρώπινη ιντερφερόνη μπορεί να είναι χρήσιμες για τη θεραπεία διαφόρων διαταραχών, για παράδειγμα τη θεραπεία αλλεργικών ασθενειών κι άλλων φλεγμονωδών καταστάσεων για παράδειγμα αλλεργικής ρινίτιδας κι άσθματος, τη θεραπεία μολυσματικών ασθενειών και καρκίνου, και μπορούν επίσης να είναι χρήσιμες ως ανοσοενισχυτικά εμβολίων.Compounds of formula (I) wherein R 1 is C 1-6 alkylamino, C 1-6 alkoxy, or C 3-7 cycloalkyloxy; m is an integer from 3 to 6; n is an integer from 0 to 4; and salts thereof are human interferon inducers. . Compounds that induce human interferon may be useful in the treatment of various disorders, for example the treatment of allergic diseases and other inflammatory conditions for example allergic rhinitis and asthma, the treatment of infectious diseases and cancer, and may also be useful as immunosuppressants.

CY20151100852T 2008-08-11 2015-09-28 Purine derivatives for use in the treatment of allergic, inflammatory and infectious diseases CY1116844T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8777708A 2008-08-11 2008-08-11
EP09781606.0A EP2324026B1 (en) 2008-08-11 2009-08-07 Purine derivatives for use in the treatment of allergic, inflammatory and infectious diseases

Publications (1)

Publication Number Publication Date
CY1116844T1 true CY1116844T1 (en) 2017-03-15

Family

ID=58459756

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20151100852T CY1116844T1 (en) 2008-08-11 2015-09-28 Purine derivatives for use in the treatment of allergic, inflammatory and infectious diseases

Country Status (1)

Country Link
CY (1) CY1116844T1 (en)

Similar Documents

Publication Publication Date Title
CY1119992T1 (en) PURINI PRODUCTS FOR USE IN THE THERAPEUTIC TREATMENT OF ALLERGIC, INFLAMMATORY AND INFECTIOUS DISEASES
CY1119557T1 (en) NEW UNIONS
EA201100114A1 (en) DERIVATIVES OF PURIN FOR USE IN THE TREATMENT OF ALLERGIC, INFLAMMATORY AND INFECTIOUS DISEASES
CY1111281T1 (en) PURINI PRODUCTS AS IMMUNITORS
CY1119368T1 (en) NEW ADENIN PRODUCERS
CY1123756T1 (en) DIPYRAZOLE DERIVATIVES AS JAK INHIBITORS
CY1119056T1 (en) 2 ', 4', - DIFFluoro-2'-Methyl-Substituted Nucleoside Derivatization as HCV RNA Replication Inhibitors
CY1123702T1 (en) PYRAZOLO[1,5-ALPHA]PYRIMIDINES USABLE AS ATR KINASE INHIBITORS FOR THE TREATMENT OF CANCER DISEASES
CY1121948T1 (en) PYRROLE [1,2,F][1,2,4]TPIAZINES USEFUL FOR THE TREATMENT OF RESPIRATORY SYMMETRICAL VIRUS INFECTIONS
CY1122863T1 (en) PHARMACEUTICAL COMPOSITION CONTAINING GLYCOPYRROLE AND A BETA2 ADRENOCEPTOR AGENT
CY1122266T1 (en) 3-AMINOCYCLALKYL COMPOUNDS AS ROR-GAMMA-T INHIBITORS AND USES THEREOF
CY1120104T1 (en) Suspensions of SYK
CY1119252T1 (en) NEW PRODUCTS 1-BENZYLO-3-HYDROXYMETHYLUNDAZOLIS AND USE THESE IN CREATIVITY BASED ON CX3CR1 AND P40 EXPRESSION
CY1113324T1 (en) Substituted Amide Derivatives as Protein Kinase Suspensions
CY1119163T1 (en) Pyridone amides as sodium channel regulators
CY1121248T1 (en) POLYMORPHIC FORMS AND SALTS 6- (1H-INDOL-4-YL) -4- (5 - {[4- (1-METHYLETHYL) -1-PIPERAZINYL] METHYL} -1,3-OXAZOL-1-Y -INDAZOLIE AS RI3K INHIBITORS FOR USE IN THERAPY BC RESPIRATORY DISORDERS
EA201590023A1 (en) NEW 4-SUBSTITUTED DERIVATIVES WITH 1,3-DIHYDRO-2H-BENZIMIDAZOLE-2-SHE, SUBSTITUTED WITH BENZIMIDAZOLES, AS ANTI-VIRUS MEANS AGAINST RESPIRATORY SYNCIAL VIRUS
BR112015022861A8 (en) bromodomain inhibitors
EA201590189A1 (en) Pyrazolopyrmidine compounds
CY1119642T1 (en) CSF-1R Suspensions for Brain Tumor Therapy
CY1110392T1 (en) Substituted morpholine and thiomorpholine derivatives
EA201270535A1 (en) PURINE DERIVATIVES APPLICABLE AS HSP90 INHIBITORS
CY1116775T1 (en) Pyrimidone derivatives as inhibitors of viral transglutaminase
PE20160120A1 (en) DERIVATIVES OF NUCLEOSIDE 4'-FLUORO-2'-METHYL SUBSTITUTED
CY1120802T1 (en) composition